Price Alert

FibroGen Inc. (FGEN)

NASDAQ: FGEN · Real-Time Price · USD

12.10

0.79 (6.98%)

At close: Sep 05, 2025, 3:59 PM

12.10

0.00%

After-hours: Sep 05, 2025, 04:10 PM EDT

FibroGen Statistics

Share Statistics

FibroGen has 4.04M shares outstanding. The number of shares has increased by -0.4% in one year.

Shares Outstanding	4.04M
Shares Change (YoY)	-0.4%
Shares Change (QoQ)	-0.91%
Owned by Institutions (%)	32.63%
Shares Floating	3.74M
Failed to Deliver (FTD) Shares	2,834
FTD / Avg. Volume	4.89%

Short Selling Information

The latest short interest is 145.3K, so 3.59% of the outstanding shares have been sold short.

Short Interest	145.3K
Short % of Shares Out	3.59%
Short % of Float	3.66%
Short Ratio (days to cover)	1.85

Valuation Ratios

The PE ratio is -27.84 and the forward PE ratio is -0.81. FibroGen's PEG ratio is 0.33.

PE Ratio	-27.84
Forward PE	-0.81
PS Ratio	44.72
Forward PS	4.5
PB Ratio	-5.87
P/FCF Ratio	-9.58
PEG Ratio	0.33

Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for FibroGen.

EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.47, with a Debt / Equity ratio of -0.32.

Current Ratio	1.47
Quick Ratio	1.45
Debt / Equity	-0.32
Debt / EBITDA	-0.51
Debt / FCF	-0.53
Interest Coverage	-18.24

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity	n/a
Return on Assets	n/a
Return on Invested Capital	n/a
Revenue Per Employee	$131.65K
Profits Per Employee	$-211.46K
Employee Count	225
Asset Turnover	0.14
Inventory Turnover	4.93

Taxes

Income Tax	-269K
Effective Tax Rate	0.18%

Stock Price Statistics

The stock price has increased by 7.06% in the last 52 weeks. The beta is 0.77, so FibroGen's price volatility has been higher than the market average.

Beta	0.77
52-Week Price Change	7.06%
50-Day Moving Average	8.18
200-Day Moving Average	9.4
Relative Strength Index (RSI)	62.39
Average Volume (20 Days)	57,913

Income Statement

In the last 12 months, FibroGen had revenue of 29.62M and earned -47.58M in profits. Earnings per share was -0.48.

Revenue	29.62M
Gross Profit	14.06M
Operating Income	-150.42M
Net Income	-47.58M
EBITDA	-142.43M
EBIT	-145.12M
Earnings Per Share (EPS)	-0.48

Full Income Statement

Balance Sheet

The company has 50.48M in cash and 73.09M in debt, giving a net cash position of -22.61M.

Cash & Cash Equivalents	50.48M
Total Debt	73.09M
Net Cash	-22.61M
Retained Earnings	-1.89B
Total Assets	178.06M
Working Capital	6.43M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -138M and capital expenditures -266K, giving a free cash flow of -138.26M.

Operating Cash Flow	-138M
Capital Expenditures	-266K
Free Cash Flow	-138.26M
FCF Per Share	-1.38

Full Cash Flow Statement

Margins

Gross margin is 47.47%, with operating and profit margins of -507.8% and -160.63%.

Gross Margin	47.47%
Operating Margin	-507.8%
Pretax Margin	-517.76%
Profit Margin	-160.63%
EBITDA Margin	-480.83%
EBIT Margin	-507.8%
FCF Margin	-466.78%

Dividends & Yields

FGEN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Payout Ratio	n/a
Earnings Yield	n/a
FCF Yield	n/a

Dividend Details

Analyst Forecast

The average price target for FGEN is $43, which is 277.9% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$43
Price Target Difference	277.9%
Analyst Consensus	Strong Buy
Analyst Count	1

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on Jun 17, 2025. It was a backward split with a ratio of 1:25.

Last Split Date	Jun 17, 2025
Split Type	backward
Split Ratio	1:25

Scores

Altman Z-Score	-17.59
Piotroski F-Score	3